Physician profile
Thomas Michael Roe
NPI 1306841739
$4,466.16
in general payments reported to CMS, 2019-2025
18 companies · $909 in 2025
The $909 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $432 · 2021: $975 · 2022: $804 · 2023: $451 · 2024: $682 · 2025: $909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,041.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,491.59 | 2021-2025 | Onyx Frontier, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $1,392.95 | 2019-2025 | Accolade Sr, Ingevity+, Lux-Dx Insertable Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $283.41 | 2023-2025 | Camzyos, Eliquis |
| Pfizer INC. | $258.86 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $247.90 | 2021-2024 | |
| Edwards Lifesciences Corporation | $185.61 | 2021-2025 | |
| Medtronic Vascular, INC. | $172.83 | 2019-2020 | |
| Abbott Laboratories | $107.26 | 2020-2024 | Jot Dx |
| Alnylam Pharmaceuticals INC. | $71.73 | 2022 | |
| Baxter Healthcare | $68.20 | 2022 | |
| Abiomed | $49.11 | 2025 | |
| Lantheus Medical Imaging, INC. | $39.62 | 2019-2023 | Definity |
| Astrazeneca Pharmaceuticals LP | $24.21 | 2024 | |
| Scpharmaceuticals INC. | $23.27 | 2025 | |
| Novo Nordisk INC | $15.13 | 2025 | Wegovy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.07 | 2023 | Xarelto |
| Argon Medical Devices, INC. | $12.07 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.34 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Roe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.